Raising the Value of PET: Technology, Reliability and Reporting Take it Up a Notch
|
|
- Nicholas Weaver
- 5 years ago
- Views:
Transcription
1 Raising the Value of PET: Technology, Reliability and Reporting Take it Up a Notch MARY C. TIERNEY, MS When we look at the future of PET, we think of new biomarkers and applications. Is conventional FDG PET maxed out? Or is there room to improve now? No it is not, and yes there is, molecular imaging experts say. While the science will advance as more specific biomarkers come to market, the slow speed of drug development can t stop the progress of PET. Imaging experts from across the globe believe there is room for PET to become more clinically powerful and more insightful for referring physicians within the current realm of applications. It s time to take a closer look at how PET is building value, now. For PET to get better, we start with improvements in access. Technologies must be accessible and available to hospitals large and small, academic and rural as well as mobile users. Novel technologies cannot remain restricted to large centers and lofty budgets. Imaging systems and software also need to be strong, smart and reliable, with exams reproducible in all sizes and types of facilities. Technology today must be better and accessible. And like all good relationships, communication among physicians is key to improving the value of patient care. The written report or its electronic counterpart must facilitate effective and efficient communication among reading physicians and referring physicians to offer diagnoses and plan treatment strategies to improve patient outcomes. Medical imaging in oncology is progressively shifting from describing the disease from an anatomic point of view to metrics, says Prof. Frédéric Courbon, MD, PhD, chief of nuclear medicine at Institut Univeristaire du Cancer de Toulouse in France and professor of nuclear medicine. It is not just about describing what structures are being seen but to convert images in number as a surrogate of either prognostic or an indication of treatment efficacy. Molecular functional imaging seeks deeper insight from a microscopic point of view and have better insight into cell biology to use imaging as a biomarker. It is a personalized treatment. It is very much about quality and accuracy of cancer detection and analysis. It comes down to the patient, says Geoffrey Johnson, MD, PhD, consultant in nuclear medicine in thoracic radiology at Mayo Clinic in Rochester, Minn. When we say there is no cancer we can see, we need the utmost confidence in imaging to support that statement. As technology increases signal and decreases noise, we are increasing the accuracy of those words our patients long to hear, no evidence of disease. That is huge. The challenges In the PET/CT imaging world, technology blends the hardware of PET and CT imaging with sophisticated software. While image quality continues to improve as better iterative reconstruction software is developed, intrinsic troubles remain in that the SPONSORED BY:
2 When we say there is no cancer we can see, we need the utmost confidence in imaging to support that statement. As technology increases signal and decreases noise, we are increasing the accuracy of those words our patients long to hear, no evidence of disease. That is huge. Geoffrey Johnson, MD, PhD, Consultant in Nuclear Medicine in Thoracic Radiology at Mayo Clinic in Rochester, Minn. amount of PET tracer in a patient and the amount of imaging time are limited by practical considerations. This limits the number of detected positron events and makes image noise higher than desired. Because of this limitation, PET images are filtered after reconstruction to make them more interpretable. The goal is to find the image that optimizes some statistic of the acquired data without contending with the associated image noise. With oncology, the emphasis on the PET side has been the detection of uptake, says Eric Rohren, MD, section chief of PET/CT and professor of nuclear medicine and radiology, MD Anderson Cancer Center in Houston. Over the years, there have been improvements in scanner technology aimed at improving the resolution and count recovery of PET/CT to see very subtle activity and differentiate that activity from physiologic background. The scanners have definitely gotten better at seeing small lesions and detecting subtle sites of activity. Yet, variability of measurements in PET is a limiting factor. The actual SUVs [standardized uptake values] we measure are not the actual SUV of the lesion, Rohren notes. They are the SUV compounded by spatial resolution, partial volume averaging and patient-specific factors we cannot control. Over the last decade, PET image reconstruction technology has been designed to provide better image quality, reduced acquisition time and lower injected dose. Current PET iterative reconstruction technologies, such as time of flight (TOF) and ordered-subsets expectation maximization (OSEM), force a compromise between image quality and quantitation. To improve the value of PET in therapy or response assessment, we need to improve the reliability and minimize the variability of SUV measurements with algorithms scan to scan. Inside the technology One way to limit noise in the PET/CT reconstruction is to stop the algorithm before the noise increases so much that it degrades the image. If the algorithm is stopped before convergence, it is important that the image has converged uniformly. To date, this has not been the case. In currently used PET/CT systems, large volumes of tracer converge more rapidly than small volumes. An organ, for example, converges before a small tumor within it. While uniformity of convergence has been improved with algorithms, no solution has led to full or nearly full convergence. Thus, PET images display quantitative artifact and may not provide an accurate SUV for all lesions. GE Healthcare has rolled out an approach that changes the paradigm by augmenting the iterative algorithm so it converges to less noisy images. Called Q.Clear, this image reconstruction software is available on all GE PET/CT systems (there s that access again), eliminating trade-offs between image quality and quantitative SUV measurements. The significant challenge with delivering consistently accurate SUV measurements in PET is that lesion size, volume and contrast recovery are highly impacted by today s reconstruction techniques. Q.Clear is a significant step forward, generating images with low noise compared to clinically widespread OSEM while increasing quantitation accuracy due to full convergence, more rigorous noise control and edge preservation. This means the SUVs delivered, Q.SUVs, are fully converged, more accurate and more consistent. It can run the reconstruction to its full convergence, up to 25 or 30 iterations, without the penalty of noise increase. Research shows 1 that by providing up to two times improvement in both quantitative accuracy (SUV mean) and image quality (SNR) in PET/CT imaging, this tool can provide bene.
3 For all lesions, you are able to get the actual measurement closer to what they are in reality. In some instances, we see things that we don t see with the [current] standard of care. Andrei Iagaru, MD, Co-chief of Nuclear Medicine at Stanford University Medical Center and Associate Professor of Radiology and Nuclear Medicine at Stanford University fits to physicians across the cancer care continuum from diagnosis and staging to treatment planning and assessment. In our experience, this method is able to suppress noise while continuing to do multiple iterations, says Andrei Iagaru, MD, co-chief of nuclear medicine at Stanford University Medical Center and associate professor of radiology and nuclear medicine at Stanford University. Stanford has been using the new reconstruction algorithm for 15 months in research projects. Clinical scans on its Discovery TM PET/CT 710 scanner started in June They come very close to what the actual object should measure, he says. This is very important for quantitation as you want to be as close as in reality to what that measurement should be and you want to do it without reducing image quality. Iagaru and his colleagues have verified measurements independently, both in phantom and clinical data. Based on our results, we plan to implement the new reconstruction algorithm in routine clinical practice. Q.Clear drives the reconstruction to full convergence. It does not solve all problems of quantitation. But at least it significantly minimizes the effect of under convergence. A PET report with multiple lesions of interest will be more consistent and reliable. If you improve the quality of the system and reduce the noise, you remove some of the reasons of uncertainty. To improve the signal to noise ratio, you will for sure improve the reproducibility, says Courbon. Iagaru says his group has found the technology very helpful in finding very small lesions where we are really able to make them more conspicuous. And for all lesions, you are able to get the actual measurement closer to what they are in reality. In some instances, we see things that we don t see with the [current] standard of care. A group at Mayo Clinic, that presented clinical data at SNMMI 2015, found that PET with Q.Clear can detect small foci of cancer with more sensitivity than without Q.Clear. That is important because you can detect smaller sites of cancer, says Johnson who was the senior author. We were able to increase the signal and reduce the background [noise] with Q.Clear compared to standard time of flight PET, and we were able to see more tiny foci of cancer. We found the numbers were just shy of 50 percent in terms of the increase in signal to noise [in certain types of cancer]. That is critically important for our ability to confidently tell a patient he or she does or do not have evidence of cancer. Johnson also sees great potential for PET as we continue to see a shift to more minimally invasive surgeries. We want better, more sensitive imaging. Advances in detecting metastatic cancers [in certain types of cancer with PET/CT or PET/MR] for example, may allow physicians to do less invasive surgeries to the benefit of patients.
4 Johnson stresses that his team, aided by Q.Clear, is more confident both when they can see potential cancer lesions that they are not fooled by noise, and more confident when no lesions are seen that there is no disease. When we are assessing whether a patient should have surgery for lung cancer, we need maximum sensitivity. With a higher degree of confidence, this allows us to say, no, I don t think there is any cancer beyond what is appropriate to remove surgically. Of all the things that Q.Clear does for clinical practice, increasing confidence that there is or is no cancer present in a given location is the most important. This changes clinical practice and patient management. Improving reliability At the end of the day, we need to be sure the number has a strong relationship with the pathological pathway needing to be blocked by a treatment, says Courbon. PET is a good methodology to assess response to biotherapy. The cornerstone is quality assurance and reproducibility. With new technology that improves the signal to noise ratio and thus contrast, physicians may identify and qualify smaller lesions with confidence. The objective is for Q.SUVs to offer referring physicians more clarity and conclusiveness. Added to reports, physicians may garner more confidence in decision making. More accurate and consistent SUV measurements will make the PET picture more equipped to track the more complex types of disease progression. Monitoring cancer treatment is not as simple as saying it is getting better, getting worse or stable. In most cases, the response is mixed with some lesions improving and others getting more active. The art of monitoring cancer treatment with PET is closely related to following not one, but several strategically chosen lesions. If conventional imaging reconstruction induces a different level of errors depending on lesion size and location, monitoring SUVs in multiple lesions becomes a real challenge. The judgment call is deciding if a particular lesion is benign or malignant. But ultimately it is understanding what impact that has on patient management. My life gets easier as I start to understand how various tumors are treated and how the patient is managed and guiding appropriate therapy, Rohren says. It is a moving target because therapy is always changing. This requires Reporting Guidance for Oncologic 18F-FDG PET/CT Imaging Clinical history Indication for study; Cancer type and site, if applicable; Brief review of treatment history, if applicable. Technique/procedure Radiopharmaceutical name; Radiopharmaceutical dose/ activity; Route of radiopharmaceutical administration; Uptake time (i.e., from radiopharmaceutical injection to imaging); Blood glucose level. Ancillary medications administered, if applicable; Precise body region scanned; CT technique (including whether oral or intravenous contrast was used; if used, name and volume of agent). Comparison studies Whether comparison was made with prior PET or PET/CT studies; include dates when available; Whether correlation was made with prior non-pet imaging studies e.g., CT or MR imaging); include dates when available. Findings Location, size/extent, and intensity of sites of abnormal 18F-FDG uptake; Abnormal PET findings correlated with concurrent CT images or correlative; imaging studies, if applicable; Incidental PET findings and Incidental CT findings. Impression Clear identification of study as normal vs. abnormal; Interpretation of findings, rather than just restatement of findings; Succinct differential diagnosis provided, if applicable; Recommendations for follow-up studies, if applicable; Documentation of communication of urgent or emergent findings to referring physician or surrogate. Source: J Nucl Med May 1, 2013 vol. 54 no
5 You can get it as close as you can with the technology but the physician needs to take it the remainder of the way. It comes down to your experience with PET, your comfort with the technology and sometimes just having seen enough scans to make those judgment calls. Eric Rohren, MD, Section Chief of PET/CT and Professor of Nuclear Medicine and Radiology, MD Anderson Cancer Center in Houston close participation with referring clinicians and participating in tumor boards and really what they need from the PET. This comes around to reporting. The ultimate goal is to answer their question. Sometimes it is overt and sometimes not really stated. We need to understand what information is important for them to know what treatment this patient should get. Rohren says it is the professional responsibility of the physician to take it to the next level. You can get it as close as you can with the technology but the physician needs to take it the remainder of the way. It comes down to your experience with PET, your comfort with the technology and sometimes just having seen enough scans to make those judgment calls. Building a better report So that brings us to reporting, step three in improving the value of PET. The report needs to contain, hold and communicate more value. Its language and contents must continually improve so that reading physicians perceive PET as more conclusive and less subjective. Improving the communication among physicians on care teams comes down to improving the language of the PET report. The more standardization the better, for the patient, the physician and the referring physician, says Iagaru, in terms of histories, details and techniques. We need consistency with accepted PET report templates, echoes Rohren who was one of the authors of SNMMI s 2013 Reporting Guidance for Oncologic 18F-FDG PET/CT Imaging that defines the essential elements of the PET/CT report. It comes down to language and interpretation of numbers. Ultimately, it is about understanding the clinical questions and designing reports that answer questions for a specific scenario. Physicians are taking note and changing their practice, although the experts agree more facilities need to dedicate more time building better, more standardized and information rich reports. There needs to be more consistency based on format, content and quality. Despite the guidelines, many are not using them, says oncologist Anthony Shields, MD, PhD, associate center director for clinical services and program leader for molecular imaging at Karmanos Cancer Institute and professor of oncology at Wayne State University. As the SNMMI guidance notes: Generating a high-quality PET/ CT report is perhaps more challenging than generating a report for other imaging studies because of the complexity of this hybrid imaging modality. 2 The content of the report not only influences patient management and clinical outcomes but also serves as legal documentation of services provided and can be used to justify medical necessity, billing accuracy and regulatory compliance. Reports should include five elements: clinical history, tech-
6 Oftentimes oncologists look at the report and not at the images. The whole picture includes both. Anthony Shields, MD, PhD, Associate Center Director for Clinical Services and Program Leader for Molecular Imaging at Karmanos Cancer Institute and Professor of Oncology at Wayne State University nique and procedure, comparison studies, findings and impression. Each element includes a series of details. Clinical studies demonstrate that the availability of clinical history increases the accuracy of radiologic image interpretation. Referring physicians play a key role too in providing an appropriate indication for the study and clearly stating the primary clinical questions to be answered by the scan. Another rule of thumb: understand the clinical situation you are imaging the best you can. Scan clinic notes for insight, Shields offers. Is it a new 3mm lesion in the lung but the liver is stable? That is the patient s life-limiting disease. The impression is the most important section of the imaging report, with many referring physicians starting there first. They read the findings section only as time allows. Oftentimes oncologists look at the report and not at the images, Shields adds. The whole picture includes both. Overall, the guidance states it is essential that all important information is presented in the impression in a clear and succinct way. The impression section should be a brief and concise interpretation of findings, not simply a restatement of findings. Lengthy discussion should be avoided in the impression. The language used should be as clear and unambiguous as possible. The impression should allow the reader to identify findings that are normal or abnormal, and answer the clinical questions raised by the referring physician. It also needs to include a clear-diagnosis or a brief list of differential diagnoses with a level of likelihood. In post-therapy follow-up studies, the metabolic response and anatomic response may be reported in the impression, especially if they are discordant. Urgent or emergent findings such as pneumothorax, impending pathologic fracture, spinal cord compression, or intracranial hemorrhage should be communicated rapidly to referring physicians or their surrogate, and the date, time and means of communication should be documented at the end of the imaging report. The best way to improve the lines of communication with radiologists is to look at the report together or while on the phone, along with the images, look at series and slices, put the cursors on the lesion for a size measurement, Shields says. Before and after images are key to assessing treatment over time. Do you think it is better or worse? Or is it somewhat uncertain? Sometimes we modify the report based on the conversation when together we change our interpretation. And don t forget the patient; patients read reports. Even with a small lesion, we need to qualify that for the patient, he says. We can t say this could be cancer. Is it likely or possible? You can frighten the patient when something is likely benign. That is not good reporting. Avoid emotional terminology, as the guidance recommends, which is not helpful and often provokes unnecessary patient anxiety. Brevity is key for the team at Mayo Clinic, Johnson notes. We try to make sure that we A. answer the clinical question and B. put forth the imaging findings in a context that is useful to the clinician while being very brief about it. Automatically adding detail and data does not excite me unless I am convinced it clarifies something or changes clinical decision-making. Depth and understanding Beyond the reporting guidelines are the quantitative numbers and subjective opinions that matter most to patient management. Quantitation is the communication language between
7 Physicians want reliable numbers, they want consistent SUVs, they want to use them Even metrics that are not perfect are related to what is very important, the clinical outcome. We should be good with that. Imaging is working. Prof. Frédéric Courbon, MD, PhD, Chief of Nuclear Medicine at Institut Univeristaire du Cancer de Toulouse in France and Professor of Nuclear Medicine reading physicians and referring physicians. Improving quantitation improves communication. The art of monitoring cancer treatment is following several strategically chosen lesions. A more confident, more clear and user- friendly report is naturally more actionable. If oncologists get more insightful guidance, they will turn more often to PET. Quantitation helps very much, says Courbon. It is up to the referring physician to make the decision carry on with toxicity or give up that there is no other solution. Sometimes it is very obvious, there are many lesions, the lesions have increased or just the opposite. But that is not for the majority of our patients. This is the gray area. Experts believe Q.Clear could improve the reading experience. With higher signal to noise ratio and more consistent quantitation, reading physicians could navigate faster around suspicious areas. This gain in efficiency would not only save time, but also enable the reader to focus on a more careful evaluation of the real areas of concern. As a consequence, they will be more empowered to call more relevant findings, with more confidence. A confident read adds a lot of value to the overall perception of the PET scan as a diagnostic tool. In the imaging community, we need to adopt these standards in reporting and quantitation so that we can take results from one center and accurately interpret it at another center, Iagaru notes. of disease and recommendations for treatment. Collectively, they are raising the value of PET. Improving the technology is the first step to improving PET s value. GE Healthcare debuted its Discovery TM IQ PET/CT system in the U.S. in September The system is designed to scan faster with lower radiation dose, provides excellent image quality and intelligent quantitation and was engineered to be economically accessible to virtually every PET center. Read that as scalable and upgradeable. The system delivers sensitivity up to 22 cps/kbq and a large axial field-of-view, up to 26 cm. Specs are one thing, performance is another. Here s where new thinking and innovation come in. Imaging experts see the difference. The technology makes it possible to perform exams with increased PET sensitivity while cutting the acquisition time and lowering the PET injected tracer dose Courbon says. Physicians want reliable numbers, they want consistent SUVs, they want to use them, Courbon notes. Everybody knows that there are drawbacks with SUV and needs of improvements, but if you compared basic SUV measurement of tumor response with the gold standard, which is survival, SUVs most of the time are strongly related to patient outcome. Even metrics that are not perfect are related to what is very important, the clinical outcome. We should be good with that. Imaging is working. Improving PET everywhere The future of PET is bright and the future is now. Affordable and upgradable-as-needed technologies ensure better access across facilities, reliable and reproducible exams that can be compared over time and reports that convey, in accurate numbers, the depth Reference 1 Ahn S, et al., Quantitative comparison of OSEM and penalized likelihood image reconstruction using relative difference penalties for clinical PET. Phys Med Biol 60: , J Nucl Med May 1, 2013 vol. 54 no Disclaimer: This article was paid for by GE Healthcare, but none of the interviewees were paid for their participation in this article.
First Clinical Experience with
First Clinical Experience with Discovery MI Digital PET/CT Martin Huellner Department of Nuclear Medicine University Hospital Zurich / University of Zurich Switzerland Agenda BelNuc GE Symposium 1. Digital
More informationBiases affecting tumor uptake measurements in FDG-PET
Biases affecting tumor uptake measurements in FDG-PET M. Soret, C. Riddell, S. Hapdey, and I. Buvat Abstract-- The influence of tumor diameter, tumor-tobackground activity ratio, attenuation, spatial resolution,
More informationQ.SUV. Quantitative SUV you and your patients can trust. GE Healthcare Q.SUV 6.4 Q.SUV 9.6. Conventional SUV 3.1 (49% Convergence)
GE Healthcare Q. 9.6 Q. 6.4 Conventional 3.1 (49% Convergence) Conventional 7.0 (73% Convergence) Q. TM Quantitative you and your patients can trust What if s were accurate and consistent? 2 Introduction
More informationComanche County Medical Center to Bring World Class Imaging to the Area
Comanche County Medical Center to Bring World Class Imaging to the Area April 23, 2008-9 am Van Dyke, Texas - - - The CCMC Board of Directors unanimously voted to move forward with purchase of several
More informationINSERT COMPANY LOGO HERE
2013 2014 INSERT COMPANY LOGO HERE 2014 North American 2013 North Positron American Emission SSL Tomography Certificate (PET) Imaging Technology Product Innovation Leadership Leadership Award Award Industry
More informationContrast-Enhanced Spectral Mammography
Contrast-Enhanced Spectral Mammography Illuminating Breast Cancer Detection SenoBright HD TM gehealthcare.com/senobright Mammography is the most reliable imaging technique for breasts, but limitations
More informationBrain Tumors. What is a brain tumor?
Scan for mobile link. Brain Tumors A brain tumor is a collection of abnormal cells that grows in or around the brain. It poses a risk to the healthy brain by either invading or destroying normal brain
More informationUse of molecular and functional imaging for treatment planning The Good, The Bad and The Ugly
Use of molecular and functional imaging for treatment planning The Good, The Bad and The Ugly Robert Jeraj, PhD Associate Professor of Medical Physics, Human Oncology, Radiology and Biomedical Engineering
More informationOptimized. clinical pathway. propels high utilization of PET/MR at Pitié-Salpêtrière Hospital
Optimized propels high utilization of PET/MR at Pitié-Salpêtrière Hospital clinical pathway As one of Europe s largest teaching hospitals, Pitié-Salpêtrière Hospital is renowned for its innovative research
More informationExpanding therapy options for
MR systems Sonalleve MR-HIFU Expanding therapy options for women s health and oncology 2 Discover the freedom of patient-friendly and non-invasive therapy options Sonalleve MR-HIFU is an innovative therapy
More informationMolecular Imaging and Cancer
Molecular Imaging and Cancer Cancer causes one in every four deaths in the United States, second only to heart disease. According to the U.S. Department of Health and Human Services, more than 512,000
More informationConversations: Let s Talk About Bladder Cancer
Understanding Biomarkers Matt Gaslky, MD, Professor of Medicine Icahn School of Medicine at Mount Sinai Piyush Agarwal, MD, Head, Bladder Cancer Section Urological Oncology Branch, National Cancer Institute
More informationsiemens.com/nx3 Scan Smarter. ACUSON NX3 Series
siemens.com/nx3 Scan Smarter. ACUSON NX3 Series Scan smarter. Rapid change in healthcare has created a real need for ultrasound imaging that is built on productivity and efficiency. Yet when faced with
More informationIdentifying Image Artifacts, Their Causes and How to Fix Them: PET. Brad J Kemp, PhD Mayo Clinic, Rochester, MN
Identifying Image Artifacts, Their Causes and How to Fix Them: PET Brad J Kemp, PhD Mayo Clinic, Rochester, MN Case 1 Can we scan with a defective block detector? Daily Quality Assurance Results Singles
More informationFast and easy diagnostic imaging from head to toe
Publication for the Philips MRI Community ISSUE 50 2014 / 1 Fast and easy diagnostic imaging from head to toe Ingenia 1.5T with dstream provides speed and convenience, IntelliSpace Portal provides flexibility
More informationBICOE Breast Imaging Center of Excellence. What is it? - Requirements. National Mammography Database. What do you get? ACR Accreditation in:
BICOE Breast Imaging Center of Excellence What is it? - Requirements William Geiser, MS DABR Senior Medical Physicist MD Anderson Cancer Center Houston, Texas wgeiser@mdanderson.org ACR Accreditation in:
More informationANNOUNCING THE NEW STONY BROOK UNIVERSITY OUTPATIENT IMAGING CENTER
ANNOUNCING THE NEW STONY BROOK UNIVERSITY OUTPATIENT IMAGING CENTER PROVIDING THE MOST ADVANCED DIAGNOSTICS FOR THE HIGHEST QUALITY OF CARE Call Our Dedicated Line: (631) 638-2121 When you need the benefit
More informationLook differently. Invenia ABUS. Automated Breast Ultrasound
Look differently. Invenia ABUS Automated Breast Ultrasound InveniaTM ABUS from GE Healthcare offers a view beyond mammography, with breast screening technology that looks differently. 40 % The unseen risk.
More informationContrast-Enhanced Spectral Mammography helps to improve breast cancer diagnostics
GE Healthcare Contrast-Enhanced Spectral Mammography helps to improve breast cancer diagnostics SenoBright TM mammography, Midwest U.S. hospital Simple test benefits clinicians and patients A hospital
More informationDenominator Criteria (Eligible Cases): Patient encounter during the performance period (CPT): 78300, 78305, 78306, 78315, 78320
Quality ID #147: Nuclear Medicine: Correlation with Existing Imaging Studies for All Patients Undergoing Bone Scintigraphy National Quality Strategy Domain: Communication and Care Coordination 2018 OPTIONS
More informationPioneering the future of general imaging.
www.siemens.com/s3000 Pioneering the future of general imaging. ACUSON S3000 Ultrasound System Answers for life. ACUSON S3000 Ultrasound System Welcome to the Family. We are thrilled you have selected
More informationCesar M. Castro, M.D., Physician Investigator at Massachusetts General Hospital/Harvard Medical School, talks about a new, tumor-detecting app.
Tumor-Detecting App Cesar M. Castro, M.D Cesar M. Castro, M.D., Physician Investigator at Massachusetts General Hospital/Harvard Medical School, talks about a new, tumor-detecting app. Doctor, if you could,
More informationPET-CT for radiotherapy planning in lung cancer: current recommendations and future directions
PET-CT for radiotherapy planning in lung cancer: current recommendations and future directions Gerry Hanna Centre for Cancer Research and Cell Biology Queen s University of Belfast @gerryhanna Talk Outline
More informationImaging Systems. Gene Saragnese EVP and GM Imaging Systems
Imaging Systems Gene Saragnese EVP and GM Imaging Systems 1 Imaging Systems Strategy Drive Customer & Patient Experience Quality, reliability and service delivery Ease of use, speed, comfort, dose Deliver
More informationInterview Guide Related to PCP and Patient Characteristics
RSNA, 2016 10.1148/radiol.2016152188 Appendix E1 Interview Guide Related to PCP and Patient Characteristics My name is and I am a research coordinator at XXX. Thank you again for agreeing to participate
More informationLung Cancer Screening
Scan for mobile link. Lung Cancer Screening What is lung cancer screening? Screening examinations are tests performed to find disease before symptoms begin. The goal of screening is to detect disease at
More informationDr. Coakley, so virtual colonoscopy, what is it? Is it a CT exam exactly?
Virtual Colonoscopy Webcast January 26, 2009 Fergus Coakley, M.D. Please remember the opinions expressed on Patient Power are not necessarily the views of UCSF Medical Center, its medical staff or Patient
More informationCollege of American Pathologists
College of American Pathologists Comments to the Food and Drug Administration on the draft guidance In Vitro Companion Diagnostics Devices October 12, 2011 College of American Pathologists 1350 I Street,
More informationTranslating Protocols Across Patient Size: Babies to Bariatric
Translating Protocols Across Patient Size: Babies to Bariatric Cynthia H. McCollough, PhD, FACR, FAAPM Professor of Radiologic Physics Director, CT Clinical Innovation Center Department of Radiology Mayo
More informationFull ultrasound breast volumes. Faster scans. Streamlined workflow. ACUSON S2000 Automated Breast Volume Scanner. Answers for life.
Full ultrasound breast volumes. Faster scans. Streamlined workflow. ACUSON S2000 Automated Breast Volume Scanner Answers for life. 1 ACQUIRE An automated whole breast solution. Reduced acquisition time.
More informationViosWorks: A Paradigm Shift in Cardiac MR Imaging
Figure 1. ViosWorks image of a patient with shunted pulmonary venous return. Image courtesy of Dr. Shreyas Vasanawala, Stanford University. ViosWorks: A Paradigm Shift in Cardiac MR Imaging The value of
More informationCAN T WE ALL JUST GET ALONG?
CAN T WE ALL JUST GET ALONG? Using the Myers-Briggs Type Indicator to Improve Workplace Relations Sara Vancil and Janet Dodson, Fall 2013 RMASFAA Preferences Can you sign your name? What is a preference?
More informationOpen up to the world. A new paradigm in hearing care
Open up to the world A new paradigm in hearing care The hearing aid industry has tunnel focus Technological limitations of current hearing aids have led to the use of tunnel directionality to make speech
More informationEcho in a Heartbeat. Article from the customer magazine Medical Solutions, April
Echo in a Heartbeat Article from the customer magazine Medical Solutions, April 2009 www.siemens.com/healthcare-magazine Echo in a Heartbeat Recently, Siemens introduced a new echocardiography system that
More informationBICOE Stereotactic Breast Biopsy and Breast Ultrasound Accreditation. Introduction. Educational Objectives
BICOE Stereotactic Breast Biopsy and Breast Ultrasound Accreditation William Geiser, MS DABR Senior Medical Physicist MD Anderson Cancer Center Houston, Texas wgeiser@mdanderson.org 1 Introduction Objectives
More informationACR MRI Accreditation Program. ACR MRI Accreditation Program Update. Educational Objectives. ACR accreditation. History. New Modular Program
ACR MRI Accreditation Program Update Donna M. Reeve, MS, DABR, DABMP Department of Imaging Physics University of Texas M.D. Anderson Cancer Center Educational Objectives Present requirements of the new
More informationLiver imaging takes a step forward with Ingenia
Publication for the Philips MRI Community ISSUE 49 2013 / 2 Liver imaging takes a step forward with Ingenia Lyon South Hospital strives to move from several studies first CT, then MR or PET to using just
More informationWhen in doubt, ask an expert
When in doubt, ask an expert MARC BEISHON No pathologist can be an expert in every type of cancer. But there is a lot that can be done to greatly improve the accuracy of diagnoses, particularly in rare
More informationBreast Cancer Screening: Improved Readings With Computers
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/advances-in-medical-imaging/breast-cancer-screening-improvedreadings-with-computers/4023/
More informationBICOE Stereotactic Breast Biopsy and Breast Ultrasound Accreditation. Introduction. Educational Objectives
BICOE Stereotactic Breast Biopsy and Breast Ultrasound Accreditation William Geiser, MS DABR Senior Medical Physicist MD Anderson Cancer Center Houston, Texas wgeiser@mdanderson.org 1 Introduction Objectives
More informationEvaluation of Monaco treatment planning system for hypofractionated stereotactic volumetric arc radiotherapy of multiple brain metastases
Evaluation of Monaco treatment planning system for hypofractionated stereotactic volumetric arc radiotherapy of multiple brain metastases CASE STUDY Institution: Odette Cancer Centre Location: Sunnybrook
More informationperformed to help sway the clinician in what the appropriate diagnosis is, which can substantially alter the treatment of management.
Hello, I am Maura Polansky at the University of Texas MD Anderson Cancer Center. I am a Physician Assistant in the Department of Gastrointestinal Medical Oncology and the Program Director for Physician
More informationAustin Radiological Association Nuclear Medicine Procedure PET SODIUM FLUORIDE BONE SCAN (F-18 NaF)
Austin Radiological Association Nuclear Medicine Procedure PET SODIUM FLUORIDE BONE SCAN (F-18 NaF) Overview Indication Sodium Fluoride F18 injection is a radioactive diagnostic agent for positron emission
More informationAustin Radiological Association Ga-68 NETSPOT (Ga-68 dotatate)
Austin Radiological Association Ga-68 NETSPOT (Ga-68 dotatate) Overview Ga-68 dotatate binds to somatostatin receptors, with highest affinity for subtype 2 receptors (sstr2). It binds to cells that express
More informationImplementation of the 2012 ACR CT QC Manual in a Community Hospital Setting BRUCE E. HASSELQUIST, PH.D., DABR, DABSNM ASPIRUS WAUSAU HOSPITAL
Implementation of the 2012 ACR CT QC Manual in a Community Hospital Setting BRUCE E. HASSELQUIST, PH.D., DABR, DABSNM ASPIRUS WAUSAU HOSPITAL Conflict of Interest Disclaimer Employee of Aspirus Wausau
More information2017 Psychology. Higher. Finalised Marking Instructions
National Qualifications 2017 2017 Psychology Higher Finalised Marking Instructions Scottish Qualifications Authority 2017 The information in this publication may be reproduced to support SQA qualifications
More informationThe power and promise of breast tomosynthesis is here. Selenia Dimensions system with Acquisition Workstation 5000
WOMEN S HEALTH BREAST SOLUTIONS HEALTH The power and promise of breast tomosynthesis is here Selenia Dimensions system with Acquisition Workstation 5000 3D mammography: A new dimension in early breast
More informationLung Cancer Screening
Scan for mobile link. Lung Cancer Screening What is lung cancer screening? Screening examinations are tests performed to find disease before symptoms begin. The goal of screening is to detect disease at
More informationA Snapshot on Nuclear Cardiac Imaging
Editorial A Snapshot on Nuclear Cardiac Imaging Khalil, M. Department of Physics, Faculty of Science, Helwan University. There is no doubt that nuclear medicine scanning devices are essential tool in the
More informationPINPOINTING RADIATION THERAPY WITH THE PRECISION OF MR.
GE Healthcare PINPOINTING RADIATION THERAPY WITH THE PRECISION OF MR. MR Radiation Oncology Suite MAXIMIZE YOUR PRECISION. HELP MINIMIZE PATIENT COMPLICATIONS. Our goal in MR radiation oncology is to
More informationNuclear Medicine and PET. D. J. McMahon rev cewood
Nuclear Medicine and PET D. J. McMahon 150504 rev cewood 2018-02-15 Key Points Nuclear Medicine and PET: Imaging: Understand how Nuc Med & PET differ from Radiography & CT by the source of radiation. Be
More informationPrecision of pre-sirt predictive dosimetry
International Course on THERANOSTICS AND MOLECULAR RADIOTHERAPY Precision of pre-sirt predictive dosimetry Hugo Levillain Department of Nuclear Medicine Medical Physics Jules Bordet Institute, Université
More informationRadiation Oncology. The conf ident path to treatment Philips Radiation Oncology Solutions
Radiation Oncology The conf ident path to treatment Philips Radiation Oncology Solutions The confident path to treatment Philips Radiation Oncology Solutions Imaging Image registration Contouring Treatment
More informationWorldwide Leading Academic Center Gets a Lift in Advanced MR Imaging
Worldwide Leading Academic Center Gets a Lift in Advanced MR Imaging As one of the largest and most authoritative scientific medical centers in Europe, Erasmus University Medical Center (Rotterdam, Netherlands),
More informationACR MRI Accreditation: Medical Physicist Role in the Application Process
ACR MRI Accreditation: Medical Physicist Role in the Application Process Donna M. Reeve, MS, DABR, DABMP Department of Imaging Physics University of Texas M.D. Anderson Cancer Center Educational Objectives
More informationTypical PET Image. Elevated uptake of FDG (related to metabolism) Lung cancer example: But where exactly is it located?
Typical PET Image Elevated uptake of FDG (related to metabolism) Lung cancer example: But where exactly is it located? PET/CT Oncology Imaging Anatometabolic fusion images are useful in the management
More informationEvaluating E&M Coding Accuracy of GoCode as Compared to Internal Medicine Physicians and Auditors
Evaluating E&M Coding Accuracy of GoCode as Compared to Internal Medicine Physicians and Auditors Evaluating E&M Coding Accuracy of GoCode as Compared to Internal Medicine Physicians and Auditors by Rhonda
More informationAdnexal Mass Management: Risk Stratification and Management Practice for Best Patient Outcomes
Transcript Details This is a transcript of a continuing medical education (CME) activity accessible on the ReachMD network. Additional media formats for the activity and full activity details (including
More informationWhen You Need To Know More.
www.siemens.com/ultrasound When You Need To Know More. ACUSON S2000 Ultrasound System Table of Contents Powerful Imaging 01 Penetrating Insight 02 03 Revealing Perspectives 04 05 Smart Workflow 06 Ergonomics
More informationBackground Information
Background Information Erlangen, November 26, 2017 RSNA 2017 in Chicago: South Building, Hall A, Booth 1937 Artificial intelligence: Transforming data into knowledge for better care Inspired by neural
More informationROLE OF PET-CT IN BREAST CANCER, GUIDELINES AND BEYOND. Prof Jamshed B. Bomanji Institute of Nuclear Medicine UCL Hospitals London
ROLE OF PET-CT IN BREAST CANCER, GUIDELINES AND BEYOND Prof Jamshed B. Bomanji Institute of Nuclear Medicine UCL Hospitals London CANCER Key facts Estimated 15.2 million new cases per year in 2015 worldwide
More informationPET/MR. Are You Ready?? Derek Lee, BS, CNMT, PET
PET/MR Are You Ready?? Derek Lee, BS, CNMT, PET Allow Myself to Introduce Myself I ve been around a while: 23+ years in Nuclear Medicine and counting PET & PET/CT for 13 years and counting Currently working
More informationPositron Emission Tomography Computed Tomography (PET/CT)
Positron Emission Tomography Computed Tomography (PET/CT) What is Positron Emission Tomography Computed Tomography (PET/CT) Scanning? What are some common uses of the procedure? How should I prepare for
More informationDianna Cody, PhD, DABR, FAAPM Professor & Clinical Operations Director Imaging Physics U.T. M.D. Anderson Cancer Center Houston, TX
Dianna Cody, PhD, DABR, FAAPM Professor & Clinical Operations Director Imaging Physics U.T. M.D. Anderson Cancer Center Houston, TX Learning Objectives: Limitations for estimating patient dose for CT Methods
More informationTRACOM Sneak Peek. Excerpts from CONCEPTS GUIDE
TRACOM Sneak Peek Excerpts from CONCEPTS GUIDE REV MAR 2017 Concepts Guide TABLE OF CONTENTS PAGE Introduction... 1 Emotions, Behavior, and the Brain... 2 Behavior The Key Component to Behavioral EQ...
More informationMolecular Imaging and Breast Cancer
Molecular Imaging and Breast Cancer Breast cancer forms in tissues of the breast usually in the ducts, tubes that carry milk to the nipple, and lobules, the glands that make milk. It occurs in both men
More informationSession 83X Dose Management: Patient and Staff Radiation Safety in Radiology
Prepared for the Foundation of the American College of Healthcare Executives Session 83X Dose Management: Patient and Staff Radiation Safety in Radiology Presented by: Bert Van Meurs Christoph Wald, MD
More informationWelcome to the RECIST 1.1 Quick Reference
Welcome to the RECIST 1.1 Quick Reference *Eisenhauer, E. A., et al. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer 2009;45:228-47. Subject Eligibility
More informationRoutine Quality Assurance Cookbook
This Cookbook is a companion guide to the AIUM Routine Quality Assurance (QA) for Diagnostic Ultrasound Equipment document, which outlines the basic QA requirements for AIUM-accredited practices. The Guide
More informationHearIntelligence by HANSATON. Intelligent hearing means natural hearing.
HearIntelligence by HANSATON. HearIntelligence by HANSATON. Intelligent hearing means natural hearing. Acoustic environments are complex. We are surrounded by a variety of different acoustic signals, speech
More informationImaging Decisions Start Here SM
Owing to its high resolution and wide anatomic coverage, dynamic first-pass perfusion 320-detector-row CT outperforms PET/CT for distinguishing benign from malignant lung nodules, researchers from Japan
More information8/10/2016. PET/CT for Tumor Response. Staging and restaging Early treatment response evaluation Guiding biopsy
PET/CT for Tumor Response Evaluation August 4, 2016 Wei Lu, PhD Department of Medical Physics www.mskcc.org Department of Radiation Oncology www.umaryland.edu FDG PET/CT for Cancer Imaging Staging and
More informationRepeatability and reproducibility of 18 F-NaF PET quantitative imaging biomarkers
Repeatability and reproducibility of 18 F-NaF PET quantitative imaging biomarkers Christie Lin, Tyler Bradshaw, Timothy Perk, Stephanie Harmon, Glenn Liu, Robert Jeraj University of Wisconsin Madison,
More informationBreast Cancer Imaging Webcast October 21, 2009 Peter Eby, M.D. Introduction
Breast Cancer Imaging Webcast October 21, 2009 Peter Eby, M.D. Please remember the opinions expressed on Patient Power are not necessarily the views of Seattle Cancer Care Alliance, its medical staff or
More informationPET in Radiation Therapy. Outline. Tumor Segmentation in PET and in Multimodality Images for Radiation Therapy. 1. Tumor segmentation in PET
Tumor Segmentation in PET and in Multimodality Images for Radiation Therapy Wei Lu, Ph.D. Department of Radiation Oncology Mallinckrodt Institute of Radiology Washington University in St. Louis Outline
More informationKeeping you focused on what you do best.
Keeping you focused on what you do best. The right diagnosis on all patients with industry-leading depth and detail. Picture the perfect ultrasound system. Now take a closer look at Toshiba s Aplio 500
More informationIngenuity TF PET/CT. Comfort and quality care in one. Your PET/CT scan with Philips Ingenuity TF PET/CT
Ingenuity TF PET/CT Comfort and quality care in one Your PET/CT scan with Philips Ingenuity TF PET/CT What s a PET/CT scan, an A PET/CT scan provides your doctor and medical specialists with valuable information
More informationAdvancing critical clinical decisions
Radiation Oncology Computed Tomography Big Bore RT Advancing critical clinical decisions Pursuit of the successful outcome Powerful technology delivers Radiation therapy can be effective in helping your
More informationBetter View. Getting a. Plus. enters new phase of clinical testing. Conducting Employee Surveys Radiology Master s Program Ground Transients
RT awardwinning magazine the weekly source for radiology professionals Getting a Better View Dedicated breast CT enters new phase of clinical testing Plus Conducting Employee Surveys Radiology Master s
More informationComputer Guided Implant Placement - Why it s a Sound Investment For Dentists
Computer Guided Implant Placement - Why it s a Sound Investment For Dentists Computer Guided Implant Placement 1 Table of Contents Overview Meeting the Challenges of Patient Demands 3 Free-hand Workflow
More informationMES 9000 MUSCULOSKELETAL EVALUATION SYSTEM
MES 9000 MUSCULOSKELETAL EVALUATION SYSTEM The new MES 9000. Now you can completely and objectively evaluate and document Dynamic Range of Motion, Static and Dynamic EMG and Muscle Testing All with one
More informationMetabolic volume measurement (physics and methods)
Metabolic volume measurement (physics and methods) Ronald Boellaard Department of Nuclear Medicine & PET Research, VU University Medical Center, Amsterdam r.boellaard@vumc.nl Metabolic volume vs tumor
More informationGE Healthcare 9900 Innovation Drive Wauwatosa, WI U.S.A.
2011 General Electric Company All rights reserved. General Electric Company reserves the right to make changes in specifications and features shown herein, or discontinue the product described at any time
More informationQ: Why is breast cancer a big deal?
I hate breast cancer. As a radiologist who specializes in breast imaging, my career is devoted to the detection and diagnosis of breast cancer. I am passionate about women s health and my goal is to find
More informationIMAGE-GUIDED RADIATION THERAPY
IMAGE-GUIDED RADIATION THERAPY Your Single Source Oncology Solutions Provider Plan. Target. Treat. At Best NOMOS, we design products and solutions that help medical professionals treat a variety of cancers.
More informationIMRT - the physician s eye-view. Cinzia Iotti Department of Radiation Oncology S.Maria Nuova Hospital Reggio Emilia
IMRT - the physician s eye-view Cinzia Iotti Department of Radiation Oncology S.Maria Nuova Hospital Reggio Emilia The goals of cancer therapy Local control Survival Functional status Quality of life Causes
More informationAustin Radiological Association BRAIN AMYLOID STUDY (F-18-Florbetapir)
Austin Radiological Association BRAIN AMYLOID STUDY (F-18-Florbetapir) Overview The Brain Amyloid Study with F-18-florbetapir depicts the extracellular deposition of B- amyloid (Aβ) peptides (or plaques
More informationComputational Neuroscience. Instructor: Odelia Schwartz
Computational Neuroscience 2017 1 Instructor: Odelia Schwartz From the NIH web site: Committee report: Brain 2025: A Scientific Vision (from 2014) #1. Discovering diversity: Identify and provide experimental
More information1 Introduction. 2 Materials and methods. LI Na 1 LI Yaming 1,* YANG Chunming 2 LI Xuena 1 YIN Yafu 1 ZHOU Jiumao 1
Nuclear Science and Techniques 20 (2009) 354 358 18 F-FDG PET/CT in diagnosis of skeletal metastases LI Na 1 LI Yaming 1,* YANG Chunming 2 LI Xuena 1 YIN Yafu 1 ZHOU Jiumao 1 1 Department of Nuclear Medicine,
More informationEndobronchial Ultrasound in the Diagnosis & Staging of Lung Cancer
Endobronchial Ultrasound in the Diagnosis & Staging of Lung Cancer Dr Richard Booton PhD FRCP Lead Lung Cancer Clinician, Consultant Respiratory Physician & Speciality Director Manchester University NHS
More informationElekta Synergy Digital accelerator for advanced IGRT
Elekta Synergy Digital accelerator for advanced IGRT Setting the standard for confident care The Field of Radiation Therapy is Constantly Changing Being able to take full advantage of the latest clinical
More informationClinician Perspective on DSM-5
Clinician Perspective on DSM-5 Physician and Non-Physician Attitudes, Perceptions and Concerns About the Release of DSM-5 in May 2013 INTRODUCTION Publication of the fifth edition of the Diagnostic and
More informationElekta Infinity Digital accelerator for advanced treatments
Elekta Infinity Digital accelerator for advanced treatments Redefining treatment precision, speed and control Confidence to increase conformance and speed without compromising target coverage Set yourself
More informationThe bright Future of Diagnostic Imaging. Paul Smit Senior Vice President Medical Systems
The bright Future of Diagnostic Imaging Paul Smit Senior Vice President Overview The role of Imaging in healthcare State of the art Philips position New developments 2 Role of imaging in healthcare Treatment
More informationAssignment 4: True or Quasi-Experiment
Assignment 4: True or Quasi-Experiment Objectives: After completing this assignment, you will be able to Evaluate when you must use an experiment to answer a research question Develop statistical hypotheses
More informationprostate cancer diagnosis and patient management
Isabelle oulay-oletta, M Groupe hospitalier Paris Saint-Joseph (St. Joseph Hospital) in Paris, France Synthetic diffusion: a robust sequence for prostate cancer diagnosis and patient management Located
More informationBest practices for a successful wellness screening program
Health & Wellness Best practices for a successful wellness screening program Identify risk. Increase engagement. Incite change. Identifying health risks in your employee population People at risk for chronic
More informationNew Approaches to Survivor Health Care
New Approaches to Survivor Health Care May 14, 2007 Survivorship Care Models Mary S. McCabe, RN Ms. McCabe is the Director of the Cancer Survivorship Program at Memorial Sloan-Kettering Cancer Center.
More informationCarotid Ultrasound Scans for Assessing Cardiovascular Risk
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/lipid-luminations/carotid-ultrasound-scans-for-assessing-cardiovascularrisk/4004/
More information45 Hr PET Registry Review Course
45 HR PET/CT REGISTRY REVIEW COURSE Course Control Document Timothy K. Marshel, MBA, R.T. (R), (N)(CT)(MR)(NCT)(PET)(CNMT) The PET/CT Training Institute, Inc. SNMMI-TS 028600-028632 45hr CEH s Voice Credits
More information